Cargando…
OMICS-based personalized oncology: if it is worth doing, it is worth doing well!
The era of Personalized Medicine implies getting the right treatment to the right patient at the right schedule and dose at the right time. Tumor biomarker tests are keys to accomplishing this goal successfully. However, much of the translational research regarding tumor biomarker tests has been hap...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876724/ https://www.ncbi.nlm.nih.gov/pubmed/24228698 http://dx.doi.org/10.1186/1741-7015-11-221 |